Susan Jackson
Clinical Research Fellow
McShane Group
RESEARCH
I am a clinical research fellow and DPhil student working in both the Tuberculosis (TB) vaccine programme at the Jenner Institute and COVID-19 clinical research at the Oxford Vaccine Group in projects headed by Professor Helen McShane. I have additionally, worked on the COVID-19 vaccine trial team headed by Professor Andrew Pollard.
Since graduating from Nottingham University with a BMedSci(hons) & BMBS(hons). I have entered the Respiratory Medicine training programme in the Thames Valley deanery with plans to return to training after completion of my DPhil.
Recent publications
Healthy volunteer experience following research bronchoscopy
Conference paper
Morrison H. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Journal article
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478